Opendata, web and dolomites

AM-SENSE

A Rapid Point-of-Care Breath Ammonia Sensor for Diagnosis of Helicobacter Pylori

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AM-SENSE project word cloud

Explore the words cloud of the AM-SENSE project. It provides you a very rough idea of what is the project "AM-SENSE" about.

pyroli    125    pyrlori    electronics    pylori    post    device    sales    carcinogen    cheaper    instant    intervention    helicobacter    societal    lethal    giving    85    sense    spread    health    biggest    retailing    ready    electrochemical    turnover    tapping    consuming    faster    period    forecast    capture    primary    infection    companies    infections    usa    completely    validate    give    treatment    decrease    electrodes    standards    clients    complete    gastric    asia    invasive    asymptomatic    59    markets    life    jobs    intensified    threatening    costly    world    diagnosis    inappropriate    35    breathalyser    ammonia    manufacturing    gold    cumbersome    time    round    delivering    technician    clinical    breath    licensing    prototype    commercialisation    screening    incidence    units    screen    market    single    gastritis    person    am    combating    accurately    intend    action    lower    million    stage    conduct    organisation    classified    integrate    cancer    radiolabelling   

Project "AM-SENSE" data sheet

The following table provides information about the project.

Coordinator
KANICHI RESEARCH SERVICES LIMITED 

Organization address
address: HOPE ROAD 41 SALE
city: MANCHESTER
postcode: M33 3BF
website: www.kanichi-research.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.breathsensing.com/contact-kanichi.htm
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-10-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KANICHI RESEARCH SERVICES LIMITED UK (MANCHESTER) coordinator 50˙000.00

Map

 Project objective

Helicobacter pylori is classified by the World Health Organisation as a carcinogen leading to gastritis and gastric cancer, the second most lethal cancer. The biggest challenge is to identify the infection at an early stage and give a more complete intervention as more than 85% of infections are asymptomatic. This makes screening/ testing an important primary action in combating H. pyrlori and its life threatening effects. Current non-invasive diagnosis methods are based on radiolabelling and are costly, cumbersome to the technician, inappropriate for wide spread clinical use and time consuming in delivering test results.

AM-SENSE is a completely new and low-cost hand held electrochemical breathalyser device to efficiently and accurately measure the presence of ammonia in a person's breath to screen for H. pyroli giving ‘instant results’. Costs per test will decrease from an average of €60 to €9.50. The key markets for our product are Europe, Asia and the USA. We project, through manufacturing, retailing and licensing of AM-SENSE a turnover of €59 million in 5 years creating 35 new jobs. A sales forecast of 125,000 units has been set for the 5 year post commercialisation period. This will result in reduced gastric cancer incidence, cheaper and faster treatment for H. pyroli infection and lower all round societal cost.

In Phase 1 we intend to test AM-SENSE against gold standards and conduct a more intensified market study, tapping into the knowledge of breathalyser companies through partnerships.

In Phase 2 we intend to integrate the electrodes and electronics with the breath capture device into a single market ready prototype and validate with potential clients.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AM-SENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AM-SENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More